More Analyst Sell Ratings as Markets Hit New Highs

Photo of Trey Thoelcke
By Trey Thoelcke Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Like any other item in the world, when a stock gets too expensive you just don’t want to buy it. The higher the market pushes, the more we see high-profile names being marched out to the analysts’ chopping block. We have seen a marked increase in the number of stocks being cut to Underperform or Sell, and some of them have been the darlings of momentum traders for the past couple of years.

At 24/7 Wall Street, we are running weekly screens across our Wall Street research coverage, looking for any and all new additions to the analysts’ Sell lists. The surge in the market to record highs on the S&P 500 and 13-year highs on the Nasdaq seems to be one reason for the higher count in the ratings changes. Plain and simple, many Wall Street analysts think some of the stocks in their coverage universe are fully valued.

Here are the new analysts Sell and Underperform ratings to hit our screens this week.

Groupon Inc. (NASDAQ: GRPN) posted numbers that at first glance looked solid, and then investors read the press release in full and the company said it was projecting a loss for the coming quarter. This was surprising, since revenue guidance was $50 million more than expected. So, the company is closing more business but making less money. RBC did not like the surprise and cut the stock to Underperform. The firm put a $6 price target on the stock. The Thomson/First Call estimate is at $11.30. Groupon closed Monday at $7.78.

L Brands Inc. (NYSE: LB) catches a downgrade at Oppenheimer to Underperform. Brean Capital joined in last week, lowering its price target on the stock ahead of fourth-quarter results on expectations of severe weather impact, weak traffic patterns and sluggish consumer spending. The firm maintained their Buy rating. Oppenheimer is much more negative and has a $46 price target for the stock. The current consensus target is $60.22. L Brands closed Monday at $53.78. Investors are paid a 2.5% dividend.

Netflix Inc. (NASDAQ: NFLX) has been the poster boy for the momentum stock traders club. The company recently announced huge deals that would keep its programming streaming smoothly on Comcast, and more deals look to be in the works. Merrill Lynch is unimpressed, and trading at 241 times earnings, it is easy to see why. This is a straight valuation call. The firm rates the stock at Underweight and has a look-out-below $226 price target. The consensus is much higher at $375.11. Netflix closed Monday at $447.00.

Panera Bread Co. (NASDAQ: PNRA) has been another momentum player’s delight over the past couple of years, and in the process mauled most of the short sellers. Piper Jaffray thinks the run may be over, and it has cut the stock to Underperform. Management has already stated that the current year’s first 48 days’ same-store sales remain weak — down 2.2% year over year. The Piper Jaffray price target is $137. The consensus target is $180.35, but Panera closed Monday at $184.41

Sears Holdings Corp. (NASDAQ: SHLD) has been in a slow, but sure death spiral for the past couple of years. The department-store chain is struggling to attract shoppers and shake off a reputation for dilapidated stores. The company has posted 27 straight quarters of falling revenue, and there is no reason to think things will get better anytime soon. The Credit Suisse price target for the Underperform-rated Sears is $20. The consensus target is close by at $22.50. Sears closed Monday at $38.05.

Strayer Education Inc. (NASDAQ: STRA) has long been a favorite target for the short sellers. The company beat estimates last week, but that was not enough to convince Deutsche Bank or Piper Jaffray. Both firms have the stock rated at Underperform, and both firms posted a $40 price objective. The consensus on Wall Street is right in line at $40.33. Strayer closed Monday at $47.26.

VIVUS Inc. (NASDAQ: VVUS) has apparently started to wear out its welcome on Wall Street. Although most firms agree its obesity drug is the best, the company cannot find a partner, and sales are disappointing. With competition from two other companies, things are not going to get any easier. Merrill Lynch (and other firms Tuesday) moved the stock to Underperform. The firm has a posted $6 price target. The consensus target is $11.30, so something has to give. The stock ended Monday at $6.75.

The market rocketed to new highs Monday, but near the end of the day a large amount of the gain was given back. That shows that traders are getting a little nervous, and they are very quick to pull the trigger and take profits. With geopolitical issues bubbling around the world, and the Chinese apparently letting their currency swan dive after months of gains, better safe than sorry may be the current mantra.

Photo of Trey Thoelcke
About the Author Trey Thoelcke →

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618